CEACAM6 and lung adenocarcinoma: Analysis of pan-cancer expression for CEACAM6 and CD24 revealed that both levels were significantly altered in a number of cancer tissues compared to their respective normal counterparts, such as breast invasive carcinoma (BRCA), lung adenocarcinoma (LUAD), and thyroid carcinoma (THCA) (Figure S4C) 23-25.